Stay updated on Gebasaxturev Combo in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Gebasaxturev Combo in Melanoma Clinical Trial page.

Latest updates to the Gebasaxturev Combo in Melanoma Clinical Trial page
- Check3 days agoChange DetectedAdded Revision: v3.4.2 to the history; removed the funding-lapse notice and Revision: v3.4.1.SummaryDifference0.4%

- Check10 days agoChange DetectedA site-wide notice about a lapse in government funding and the NIH Clinical Center’s status was added, along with the new page revision label Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check17 days agoChange DetectedUI updates add a glossary toggle and color-coded change indicators (green for additions, red for deletions). Revision notes update to v3.4.0 and adjust the 'No FEAR Act data' wording from the previous version.SummaryDifference0.5%

- Check31 days agoChange DetectedThe record history now includes a new revision entry v3.3.4 and removes the previous entry v3.3.3. This is a minor platform update and does not affect the trial information.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision: v3.3.3 was added to the history; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check81 days agoChange DetectedThe history now adds Revision: v3.3.2 and removes Revision: v3.2.0; this is a minor metadata update to the record history that does not affect study data or status.SummaryDifference0.1%

Stay in the know with updates to Gebasaxturev Combo in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gebasaxturev Combo in Melanoma Clinical Trial page.